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OBJECTIVE—Cytokines contribute to -cell destruction in type
1 diabetes. Endoplasmic reticulum (ER) stress–mediated apopto-
sis has been proposed as a mechanism for -cell death. We tested
whether ER stress was necessary for cytokine-induced -cell
death and also whether ER stress gene activation was present in
-cells of the NOD mouse model of type 1 diabetes.
RESEARCH DESIGN AND METHODS—INS-1 -cells or rat
islets were treated with the chemical chaperone phenyl butyric
acid (PBA) and exposed or not to interleukin (IL)-1 and
-interferon (IFN-). Small interfering RNA (siRNA) was used to
silence C/EBP homologous protein (CHOP) expression in INS-1
-cells. Additionally, the role of ER stress in lipid-induced cell
death was assessed.
RESULTS—Cytokines and palmitate triggered ER stress in
-cells as evidenced by increased phosphorylation of PKR-like
ER kinase (PERK), eukaryotic initiation factor (EIF)2, and Jun
NH2-terminal kinase (JNK) and increased expression of activat-
ing transcription factor (ATF)4 and CHOP. PBA treatment atten-
uated ER stress, but JNK phosphorylation was reduced only in
response to palmitate, not in response to cytokines. PBA had no
effect on cytokine-induced cell death but was associated with
protection against palmitate-induced cell death. Similarly, siRNA-
mediated reduction in CHOP expression protected against palmi-
tate- but not against cytokine-induced cell death. In NOD islets,
mRNA levels of several ER stress genes were reduced (ATF4, BiP
[binding protein], GRP94 [glucose regulated protein 94], p58, and
XBP-1 [X-box binding protein 1] splicing) or unchanged (CHOP
and Edem1 [ER degradation enhancer, mannosidase –like 1]).
CONCLUSIONS—While both cytokines and palmitate can induce
ER stress, our results suggest that, in contrast to lipoapoptosis, the
PERK-ATF4-CHOP ER stress–signaling pathway is not necessary
for cytokine-induced -cell death. Diabetes 57:3034–3044, 2008
T
ype 1 diabetes is mediated by an autoimmune
and inﬂammatory process ultimately leading to
pancreatic -cell death. Cytokines, such as inter-
leukin (IL)-1 and -interferon (IFN-), are me-
diators of -cell death, possibly via the generation of nitric
oxide (NO) (1–5). However, the mechanisms by which
-cells are destroyed remain to be clariﬁed.
Recent studies have proposed that cytokine-induced
-cell death involves endoplasmic reticulum (ER) stress
(6–8). The ER stress response is an evolutionarily con-
served, adaptive program triggered by accumulation of
unfolded protein in the lumen of the ER (9,10). Upon
initiation of ER stress, cells activate intracellular signaling
pathways that transmit information from the ER to the
cytoplasm and nucleus, known as the unfolded protein
response (UPR). The UPR includes transient attenuation
of de novo protein synthesis that limits protein load on the
ER. This is followed by transcriptional activation of genes
encoding ER chaperones to increase protein folding ca-
pacity in the ER and proteins involved in ER-associated
degradation to eliminate misfolded proteins by the ubiq-
uitin-proteasome system. When functions of the ER are
severely or irreversibly impaired, the UPR activates apo-
ptosis. Signaling from the ER is initiated by ER-localized
stress sensors PKR-like ER kinase (PERK), activating
transcription factor (ATF)6, and inositol-requiring (IRE)1,
which remain inactive under nonstress conditions due to
association of their ER luminal domains with binding
protein (BiP) (11). Upon accumulation of unfolded pro-
tein, BiP dissociates from the sensor proteins, leading to
their activation. PERK activation by phosphorylation leads
to phosphorylation of the eukaryotic initiation factor
(EIF)2, which in turn leads to translational attenuation
and induction of ATF4 (12). ER stress can lead to apopto-
sis by various pathways, including via ATF4 transcrip-
tional activation of the gene for C/EBP homologous
protein (CHOP) (13–15) and activation of Jun NH2-termi-
nal kinase (JNK) and caspase-12 (9,10).
The importance of ER stress signaling in regulating
-cell function and survival was ﬁrst demonstrated in
PERK-deﬁcient mice (16) and in mice with a mutation in
the EIF2 phosphorylation site (Ser51Ala) (17,18). Other
experiments in the Akita mouse have shown that -cell
apoptosis and diabetes could be delayed by inhibiting
CHOP induction (14). That ER stress is at least partially
required for lipoapoptosis in -cells was suggested by the
recent ﬁnding that MIN6 cells overexpressing BiP are
partially protected against apoptosis induced by the satu-
rated fatty acid palmitate (19). Furthermore, increased ER
stress gene expression has been observed in islets of db/db
mice (19) and humans with type 2 diabetes (19,20). The
relevance of ER stress signaling to -cell destruction in
type 1 diabetes was suggested in studies showing that
treatment of -cells with cytokines or NO leads to in-
creased expression of ATF4 and CHOP (6–8) and that
pancreatic islets depleted in CHOP are partially protected
against NO-induced cell death (6). These correlations led
us to investigate the role of ER stress in cytokine-induced
-cell death and the development of type 1 diabetes. For
comparison, we also assessed the role of ER stress in
lipid-induced -cell death.
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Cell culture. INS-1 cells were passaged in RPMI-1640 medium (Invitrogen,
Carlsbad, CA) supplemented with 0.2 mmol/l glutamine, 10 mmol/l HEPES,
10% heat-inactivated FBS, 100 units/ml penicillin, 100 g/ml streptomycin, 1
mmol/l sodium pyruvate, and 50 mol/l 2-mercaptoethanol. MIN6 cells were
passaged in Dulbecco’s modiﬁed Eagle’s medium (DMEM) (Invitrogen) con-
taining 25 mmol/l glucose, 10 mmol/l HEPES, 10% FCS, 100 units/ml penicillin,
and 100 g/ml streptomycin. Cells were seeded at either 1–1.5  10
5 in 0.5 ml
per well in a 24-well plate or at 5  10
5 in 2 ml per well in a 6-well plate. Cells
were pretreated with the chemical chaperones phenyl butyric acid (PBA) (2.5
mmol/l; Sigma, St. Louis, MO) or trimethylamine N-oxide (TMAO) (100
mmol/l) for 24 h. Cells were then treated with PBA or TMAO in combination
with 50 units/ml IL-1 and 100 units/ml IFN- (R&D Systems, Minneapolis,
MN) or 0.4 mmol/l palmitate coupled to 0.92% BSA (palmitate to BSA molar
ratio 3:1) (Sigma). Cell death was measured with an ELISA kit (Cell Death
Detection ELISA; Roche Diagnostics, Castle Hill, Australia) (21). NO was
measured in culture media using Griess reagent.
Rat islet isolation and culture. Islets were isolated from male Wistar rats
(175–200 g) by pancreatic digestion with liberase RI (Roche Diagnostics).
Islets were further separated with a Ficoll-Paque PLUS gradient (GE Health-
care Bio-Sciences, Uppsala, Sweden) and handpicked under a stereomicro-
scope. Procedures were approved by the Garvan Institute/St.Vincent’s
Hospital Animal Experimentation Ethics Committee following guidelines
issued by the National Health and Medical Research Council of Australia.
Islets were cultured for 3–4 days at 37°C in RPMI-1640 medium supplemented
with 0.2 mmol/l glutamine, 10% heat-inactivated FBS, 100 units/ml penicillin,
and 100 g/ml streptomycin. Islets with central necrosis were discarded, and
those of similar size were then pretreated with 2.5 mmol/l PBA for 24 h. Islets
were then treated for 16 h with 2.5 mmol/l PBA in combination with 50
units/ml IL-1 and 100 units/ml IFN-. Cell death was assessed as above, and
RNA was extracted for RT-PCR analysis.
Plasmid construction and transfection. Rat BIP cDNA was ampliﬁed by
PCR, cloned into the Gateway donor vector pDONR 221, and then subcloned
into the Gateway expression vector pcDNA-DEST40 (Invitrogen). Two days
before transfection, INS-1 cells were seeded at 3  10
5 cells per well in a
12-well plate. BIP-DEST40 or control pmaxGFP (green ﬂuorescent protein)
was transfected into INS-1 cells using Lipofectamine 2000 (Invitrogen) with
80% transfection efﬁciency. Twenty four hours later, cells were treated with
cytokines (50 units/ml IL-1 and 100 units/ml IFN-).
CHOP (DDIT3) ON-TARGETplus SMARTpool siRNA or negative control
nontargeting siRNA were transfected into INS-1 cells using DharmaFECT
Transfection Reagent (Dharmacon, Lafayette, CO). Forty eight hours later,
cells were treated with cytokines (50 units/ml IL-1 and 100 units/ml IFN-)o r
0.4 mmol/l palmitate coupled to 0.92% BSA.
Wild-type CHOP and a dominant-negative mutant CHOP construct lacking
the basic DNA-binding region (CHOPBR) were gifts from Prof. Nicholas
Hoogenraad (22). Wild-type CHOP, CHOPBR, or pmaxGFP were electropo-
rated into MIN6 cells by nucleofection (AMAXA Biosystems, Cologne, Ger-
many), according to the manufacturers’ instructions, with 70% transfection
efﬁciency. Cells were seeded at 5  10
5 cells in 1 ml of DMEM per well in a
12-well plate. After 24 h, cells were treated with cytokines (50 units/ml IL-1,
100 units/ml IFN-, and 100 units/ml tumor necrosis factor [TNF]-; R&D
Systems, Minneapolis, MN).
Western blotting. Total protein levels were measured (Bio-Rad Protein
Assay; Bio-Rad Laboratories, Hercules, CA), and 20–50 g protein per lane
was separated on NuPage SDS-PAGE gels (Invitrogen) and transferred to
polyvinylidine diﬂuoride membrane. Membranes were incubated in primary
antibodies for either 1–2 h at room temperature or overnight at 4°C. The
following antibodies were used (1:1,000 dilution unless otherwise indicated):
CHOP (sc-575), total EIF2 (sc-11386), ATF4 (sc-200), and inducible NO
synthase (iNOS) (NOS2, N-20, sc-651, 1:400) (Santa Cruz Biotechnology, Santa
Cruz, CA); phospho-PERK (Thr980, 16F8, 3179), phospho-EIF2 (Ser51, 9721),
phospho-JNK (Thr183/Tyr185, 9251), total JNK (9252), and cleaved caspase-3
(Asp175, 9664, 1:500) (Cell Signaling Technology, Danvers, MA); and BiP
(generously provided by Dr. Linda Hendershot, St. Jude Children’s Research
Hospital, Memphis, TN). Equal loading of protein between lanes was con-
ﬁrmed by subsequent -actin immunoblots (-actin 1:5,000; Sigma). After
incubation with horseradish peroxidase–conjugated goat anti-mouse or don-
key anti-rabbit (1:5,000; Jackson ImmunoResearch Laboratories, West
Grove, PA) antibody for1ha troom temperature, immunodetection was
performed by chemiluminescence (PerkinElmer, Wellesley, MA; or Milli-
pore, Billerica, MA).
RNA analysis. Total RNA was extracted from cells or islets, and real-time
PCR was performed using a LightCycler (Roche Diagnostics) (23). Oligonu-
cleotide primer sequences (Supplementary Table 1 [available in an online
appendix at http://dx.doi.org/10.2337/db07-1802]) were designed with MacVec-
tor software (Oxford Molecular Ltd.). The values obtained for each speciﬁc
product was normalized to the control gene (cyclophilin A) and expressed as
a percent of the value in control extracts. Xbp1 cDNA was ampliﬁed by PCR
and digested with PstI, which cuts unprocessed Xbp1 cDNA into fragments.
Processed (activated) Xbp1 cDNA lacks the restriction site and remains intact.
Processed (intact) and unprocessed (cut) Xbp1 was quantiﬁed by densitom-
etry. The value obtained for processed Xbp1 was expressed as a ratio of the
total (processed  unprocessed) Xbp1 mRNA levels for each sample. These
ratios are expressed as a percentage of the ratio in control INS-1 cells.
NOD mice. Nonobese diabetic (NOD/LtJ) and C57BL/6J mice were obtained
from ARC (Perth, WA, Australia). Islets were isolated from 13- to 18-week-old
mice as described above. RNA extraction was performed immediately follow-
ing islet collection.
Statistical analysis. All results are presented as means 	 SEM. Statistical
analyses were performed using Student’s t test or one-way ANOVA.
RESULTS
PBA attenuates cytokine-induced ER stress in INS-1
cells. We ﬁrst tested whether PBA was capable of atten-
uating ER stress induced by cytokines in INS-1 cells. PBA
acts as a chemical chaperone to reduce the load of
unfolded proteins in the ER by improving folding capacity
and trafﬁcking of mutant proteins out of the ER (24). In
control (non–PBA-treated) INS-1 cells, IL-1IFN-
treatment induced ER stress after both 6 and 24 h, as
evidenced by increased phosphorylation of PERK (Fig. 1A
and B) and EIF2 (Fig. 1A and C) and increased protein
expression (Fig. 1A, D, and E) and mRNA levels (Fig. 1F
and G) of ATF4 and CHOP. In PBA-treated INS-1 cells, ER
stress due to IL-1IFN- was attenuated, as indicated
by reduced PERK (Fig. 1A and B) and EIF2 phosphory-
lation (Fig. 1A and C) and reduced protein expression (Fig.
1A, D, and E) and mRNA levels (Fig. 1F and G) of ATF4
and CHOP.
PBA does not protect against cytokine-induced cell
death in INS-1 cells. We tested the sensitivity of PBA-
treated INS-1 cells to cytokine-mediated cytotoxicity. In
control (non–PBA-treated) INS-1 cells, IL-1IFN-
treatment led to a signiﬁcant increase in cell death after
both 6 and 24 h (Fig. 1H). However, PBA treatment did not
protect INS-1 cells from cytokine-induced cell death; IL-
1IFN-–induced cell death was similar in control and
PBA-treated cells after both 6 and 24 h (Fig. 1H). Thus,
PBA-treated cells retain their sensitivity to IL-1IFN-
cytotoxicity despite the attenuation of ER stress, suggest-
ing that ER stress induced by cytokines is not required for
-cell death.
PBA protects against palmitate-induced cell death
and ER stress in INS-1 cells. We also tested the sensi-
tivity of PBA-treated INS-1 cells to lipotoxicity induced by
the saturated fatty acid palmitate. In control INS-1 cells,
treatment with 0.4 mmol/l palmitate for 6 h led to a
signiﬁcant increase in cell death (Fig. 2F). Palmitate
treatment of control INS-1 cells was also associated with
induction of ER stress, as indicated by increased phos-
phorylation of PERK (Fig. 2A and B) and EIF2 (Fig. 2A
and C) and increased expression of ATF4 (Fig. 2A and D)
and CHOP (Fig. 2A and E). In PBA-treated INS-1 cells,
palmitate-induced ER stress was attenuated, as indicated
by reduced PERK (Fig. 2A and B) and EIF2 (Fig. 2A and
C) phosphorylation and decreased expression of ATF4
(Fig. 2A and D) and CHOP (Fig. 2A and E). Strikingly, this
was associated with a complete block of palmitate-
induced cell death in PBA-treated INS-1 cells (Fig. 2F).
Thus, PBA-treated cells acquired selective resistance to
the toxic effects of palmitate. These data suggest that,
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DIABETES, VOL. 57, NOVEMBER 2008 3035unlike cytokines, ER stress is required for lipid-induced
cell death in -cells.
We further assessed the role of ER stress in -cell
death using another chemical chaperone, trimethyl-
amine oxide (TMAO). Treatment of INS-1 cells with
TMAO reduced ER stress, as indicated by decreased
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plementary Fig. 1A and B) and cytokine-treated (Sup-
plementary Fig. 2A and B) INS-1 cells. This was
associated with reduced cell death in palmitate-treated
cells (Supplementary Fig. 1C), whereas cytokine-
induced cell death was not affected (Supplementary Fig.
2C). Thus, the data using TMAO support the suggestion
that ER stress is required for lipid- but not for cytokine-
induced cell death. We also examined cleaved caspase-3
expression under these experimental conditions. Cleaved
caspase-3 expression was induced in both palmitate- (Sup-
plementary Fig. 3A) and cytokine-treated (Supplementary
Fig. 3B) INS-1 cells. In PBA- and TMAO-treated INS-1 cells,
cleaved caspase-3 expression was reduced in response to
palmitate (Supplementary Fig. 3A) and not in response
cytokines (Supplementary Fig. 3B).
PBA treatment does not lower cytokine-induced
iNOS expression or NO production in INS-1 cells. To
check that the ability of PBA to attenuate cytokine-
induced ER stress was not due to lower NO production,
we measured iNOS expression and NO production after
cytokine exposure in control and PBA-treated -cells.
Treatment of INS-1 cells with IL-1IFN- led to an
increase in iNOS expression (Fig. 3B) and stimulated
production of NO (Fig. 3A). With PBA treatment, cytokine-
induced iNOS expression and NO production were not
FIG. 1. The chemical chaperone PBA reduces cytokine activation of genes involved in ER stress in INS-1 cells but does not protect against
cytokine-induced cell death. INS-1 cells grown in RPMI-1640 were pretreated in the absence or presence of PBA (2.5 mmol/l) for 24 h and then
cultured in combination with IL-1 (50 units/ml) and IFN- (100 units/ml) for 6 or 24 h as indicated. A: Western blot analysis comparing changes
in PERK and EIF2 phosphorylation (p) and expression of ATF4 and CHOP. Total EIF2 and -actin protein served as loading controls. pPERK
(B), pEIF2 (C), ATF4 (D), and CHOP (E) bands were quantiﬁed by densitometry and are expressed as fold change compared with control.
Results are means  SEM determined from three to four experiments. *P < 0.05, **P < 0.01 for PBA  cytokine-treated versus control
cytokine-treated INS-1 cells at the same time point. ATF4 (F) and CHOP (G) mRNA levels. Total RNA was extracted and analyzed by real-time
RT-PCR. Results are means  SEM determined from three experiments performed in triplicate or quadruplicate and are expressed as fold-change
of mRNA levels in control INS-1 cells. *P < 0.05, **P < 0.01 for PBA  cytokine-treated versus control cytokine-treated INS-1 cells at the same
time point. H: Cell death was measured using a cell death detection ELISA. Results are means  SEM determined from three experiments
performed in triplicate and are expressed as fold change compared with control untreated INS-1 cells at each time point. *P < 0.05, **P < 0.01,
***P < 0.001 versus control untreated INS-1 cells at the same time point.
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with palmitate, we found no induction of iNOS expression
and no stimulation of NO production (data not shown).
PBA treatment lowers palmitate-induced XBP1 splic-
ing, whereas cytokines do not activate XBP1 in INS-1
cells. We next examined ER stress signaling downstream
of IRE1 by assessing XBP1 splicing. Palmitate treatment
led to an increase in the spliced form of XBP1 mRNA in
INS-1 cells (Fig. 4A), indicating activation. In contrast,
cytokine treatment was associated with reduced XBP1
splicing in INS-1 cells (Fig. 4B), suggesting reduced signal-
ing via this arm of the ER stress response. In PBA-treated
cells, palmitate activation of XBP1 was attenuated, as
indicated by reduced mRNA levels of the spliced form
(Fig. 4A).
PBA lowers JNK phosphorylation in response to
palmitate but not in response to cytokines. We next
examined JNK phosphorylation (activation), which can
also be stimulated by ER stress downstream of IRE1 (25).
Increased phosphorylation of JNK1 (46 kDa) and JNK2 (54
kDa) was observed in both palmitate- (Fig. 5A–C) and
cytokine-treated (Fig. 5D–F) INS-1 cells. PBA treatment
FIG. 2. PBA treatment protects against palmitate-induced ER stress
and cell death in INS-1 cells. INS-1 cells grown in RPMI-1640 were
pretreated in the absence or presence of PBA (2.5 mmol/l) for 24 h and
then cultured in combination with 0.4 mmol/l palmitate coupled to
0.92% BSA for6ha sindicated. A: Western blot analysis comparing
changes in PERK and EIF2 phosphorylation (p) and expression of
ATF4 and CHOP. Total EIF2 and -actin protein served as loading
controls. pPERK (B), pEIF2 (C), ATF4 (D), and CHOP (E) bands
were quantiﬁed by densitometry and are expressed as fold change
compared with control. Results are means  SEM determined from
three to four experiments. *P < 0.05, **P < 0.01 for PBA  palmitate-
treated versus control palmitate-treated INS-1 cells. F: Cell death was
measured using a cell death detection ELISA. Results are means  SEM
determined from three experiments performed in triplicate and are
expressed as fold change compared with control. *P < 0.05 for control
palmitate-treated versus control untreated INS-1 cells, †P < 0.05 for
PBA  palmitate-treated versus control palmitate-treated INS-1 cells.
FIG. 3. PBA treatment does not lower cytokine-induced iNOS expres-
sion or NO production in INS-1 cells. INS-1 cells were treated with PBA
(2.5 mmol/l) for 24 h and then cultured in combination with IL-1 (50
units/ml) and IFN- (100 units/ml) for 6 or 24 h as indicated. A: Medium
was taken to determine levels of NO production by the Griess reaction.
Results are means  SEM. n  5 in each group. B: Western blot analysis
comparing changes in iNOS expression. Representative images are
shown from two experiments.
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(Fig. 5A–C), suggesting that ER stress is required for
palmitate-induced JNK activation. In contrast, cytokine-
induced JNK1/2 phosphorylation was not signiﬁcantly
altered by PBA treatment (Fig. 5D–F), suggesting that ER
stress is not required for cytokine-induced JNK activation.
Thus, ER stress-independent activation of JNK may pro-
vide a mechanism for the inability of PBA to protect
against cytokine-induced cell death.
PBA does not protect against cytokine-induced cell
death in primary islets. We next tested in rat islets
whether attenuation of ER stress with PBA altered the
sensitivity of primary -cells to cytokine-induced cell
death. In control rat islets, IL-1IFN- treatment for
16 h led to a signiﬁcant increase in cell death (Fig. 6A), as
well as increased ATF4 and CHOP mRNA levels (Fig. 6B),
suggestive of UPR activation. In PBA-treated islets, expo-
sure to cytokines led to signiﬁcantly reduced ATF4 and
CHOP mRNA levels compared with cytokine-treated con-
trol islets (Fig. 6B). However, in PBA-treated islets, cyto-
kine-induced cell death was similar to that in control islets
(Fig. 6A). Thus, the PBA-mediated reduction in UPR
activation had no effect on cytokine-induced cell death in
primary islets. These data are in accordance with the
results obtained in INS-1 cells and conﬁrm the suggestion
that ER stress is not required for cytokine-induced -cell
death in islets.
BiP overexpression does not protect INS-1 cells from
cytokine-induced cell death. The overexpression of the
ER chaperone BiP attenuates ER stress in -cells (19), as
it does in other cell types (11,13,26). BiP acts as an ER
resident molecular chaperone by enhancing protein fold-
ing and maintaining PERK, ATF6, and IRE1 in their
inactive states (11). We previously demonstrated that
lipid-induced cell death was signiﬁcantly reduced in BiP-
overexpressing -cells (19). Here, we tested whether BiP
overexpression inﬂuenced cytokine-induced toxicity in
-cells. INS-1 cells were transfected with an expression
vector encoding BiP or GFP (Fig. 7A) and then cultured in
the absence or presence of cytokines. Cell death induced
by IL-1IFN- was similar in GFP- and BiP-overexpress-
ing INS-1 cells (Fig. 7B), despite lowered CHOP expres-
sion in BiP-overexpressing cells (Fig. 7C). Similarly, in
studies with MIN6 cells, overexpressing murine BiP had
no inﬂuence on cytokine-induced cell death (data not
shown). These data indicate that BiP-overexpressing
-cells retain their sensitivity to the toxic effects of
cytokines.
siRNA-mediated silencing of CHOP expression in
-cells protects against palmitate- but not against
cytokine-induced cell death. In a previous study (6), a
modest reduction in cell death induced by cytokines was
observed in islets from CHOP-deﬁcient mice. To assess the
FIG. 4. Palmitate activates, whereas cytokines reduce, XBP1 splicing in
INS-1 cells. PBA treatment lowers palmitate-induced XBP1 splicing.
INS-1 cells were pretreated in the absence or presence of PBA (2.5
mmol/l) for 24 h and then cultured for6hi ncombination with the
absence () or presence (f) of either 0.4 mmol/l palmitate coupled to
0.92% BSA (A), or IL-1 (50 units/ml) and IFN- (100 units/ml) (B).
Total RNA was extracted and reverse transcribed. Xbp1 cDNA was
ampliﬁed by PCR and digested with PstI, which cuts unprocessed Xbp1
cDNA into fragments. Processed (activated) Xbp1 cDNA lacks the
restriction site and remains intact. Processed (intact) and unprocessed
(cut) Xbp1 was quantiﬁed by densitometry. The value obtained for
processed Xbp1 was expressed as a ratio of the total (processed 
unprocessed) Xbp1 mRNA levels for each sample. These ratios are
expressed as a percentage of the ratio in control INS-1 cells. Results
are means  SEM determined from three experiments performed in
triplicate or quadruplicate. A: ***P < 0.001 versus control untreated
INS-1 cells, †††P < 0.001 for PBA  palmitate-treated versus control
palmitate-treated INS-1 cells. B: ***P < 0.001 versus control untreated
INS-1 cells.
FIG. 5. PBA treatment reduces JNK phosphorylation in response to
palmitate but not in response to cytokines. INS-1 cells were pretreated
in the absence or presence of PBA (2.5 mmol/l) for 24 h and then
cultured for6hi ncombination with the absence or presence of 0.4
mmol/l palmitate coupled to 0.92% BSA (A–C) or IL-1 (50 units/ml)
and IFN- (100 units/ml) (D–F). A and D: Western blot analysis
comparing changes in JNK phosphorylation (p). Total JNK protein
served as loading control. pJNK1 (46 kDa) (B and E) and pJNK2 (54
kDa) (C and F) bands were quantiﬁed by densitometry and are
expressed as fold change compared with control. Results are means 
SEM determined from three experiments. ***P < 0.001 for PBA 
palmitate-treated versus control palmitate-treated INS-1 cells.
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cells were transfected with CHOP siRNA or control siRNA.
CHOP siRNA transfection led to reduced CHOP expres-
sion in INS-1 cells exposed to palmitate (Fig. 8A and B)o r
cytokines (Fig. 8E and F) compared with control siRNA-
transfected cells. This resulted in protection against palmi-
tate-induced cell death (Fig. 8D) and reduced cleaved
caspase-3 expression in response to palmitate (Fig. 8A and
C). In contrast, siRNA-mediated reduction of CHOP ex-
pression had no effect on cell death (Fig. 8H) or cleaved
caspase-3 expression (Fig. 8E and G) induced by cyto-
kines. This evidence suggests that CHOP expression is
necessary for lipid- but not for cytokine-induced -cell
death.
To further assess the role of CHOP as a potential
mediator of cytokine-induced -cell death, MIN6 cells
were transfected with CHOP, CHOPBR (dominant-nega-
tive mutant), and GFP constructs (Supplementary Fig.
4A). By immunostaining, we conﬁrmed that overexpressed
CHOP was localized in the nucleus of transfected cells
(not shown). Furthermore, induction of CHOP target
genes Gadd34 and Car6 in CHOP-overexpressing cells was
blocked in cells cotransfected with CHOP and CHOPBR
(Supplementary Fig. 4B). In tissues other than -cells,
overexpression of CHOP is sufﬁcient to induce cell death
(15,27–30). Here, under basal conditions, the rate of cell
death in CHOP-overexpressing MIN6 cells was not differ-
ent compared with control GFP-expressing MIN6 cells
FIG. 6. Attenuation of ER stress with PBA does not protect against
cytokine-induced cell death in primary rat islets. Isolated rat islets
were pretreated in the absence or presence of PBA (2.5 mmol/l) for
24 h and then cultured in combination with the IL-1 (50 units/ml) and
IFN- (100 units/ml) for 16 h. A: Cell death was measured using a cell
death detection ELISA. Results are means  SEM determined from
three experiments performed in triplicate and are expressed as fold
change compared with control untreated islets. ***P < 0.001 versus
control untreated islets. B: Total RNA was extracted from islets and
ATF4 and CHOP mRNA levels analyzed by real-time RT-PCR. Results
are means  SEM determined from four experiments performed in
duplicate and are expressed as fold change of mRNA levels in control
untreated islets. **P < 0.01, ***P < 0.001 for PBA  cytokine-treated
versus control cytokine-treated islets.
FIG. 7. BiP overexpression does not protect INS-1 cells from cytokine-
induced cell death. INS-1 cells were transfected with an expression
vector encoding for BIP (pBIP-DEST40) or GFP (pmaxGFP) by lipo-
fectamine. A: Western blot analysis of BiP in GFP- and BiP-overex-
pressing INS-1 cells. -Actin served as a loading control. B: Effect of
BiP overexpression on cytokine-induced cell death in INS-1 cells. BiP-
and GFP-overexpressing INS-1 cells were cultured in the absence ()
or presence (f) of IL-1 (50 units/ml) and IFN- (100 units/ml). Cell
death was measured using a cell death detection ELISA. Results are
means  SEM determined from three experiments performed in trip-
licate. ***P < 0.001 versus untreated GFP-overexpressing cells. C:
Effect of BiP overexpression on cytokine-induced CHOP expression in
INS-1 cells. Western blots analyzing CHOP protein were quantiﬁed by
densitometry and are expressed as fold change compared with un-
treated GFP-overexpressing cells. Results are means  SEM deter-
mined from three experiments. *P < 0.05 for cytokine-treated BiP-
overexpressing cells versus cytokine-treated GFP-overexpressing
cells.
ROLE OF ENDOPLASMIC RETICULUM STRESS IN -CELL DEATH
3040 DIABETES, VOL. 57, NOVEMBER 2008(Supplementary Fig. 4C). This indicates that increased
expression of CHOP alone is not sufﬁcient to trigger MIN6
-cell death. Furthermore, after cytokine (IL-1IFN-
TNF-) exposure, the induction in cell death did not differ
in GFP- and CHOP-overexpressing cells (Supplementary
Fig. 4C). In CHOPBR-overexpressing MIN6 cells, the
basal and cytokine-stimulated rate of cell death was
similar to that in control GFP-expressing cells (Supple-
mentary Fig. 4C). Thus, the overexpression or inhibition of
CHOP in MIN6 cells does not inﬂuence cell viability under
basal conditions or after exposure to cytokines. Similar
results were found in INS-1 cells transfected with GFP,
CHOP, and CHOPBR and subsequently treated with
IL-1IFN- (data not shown).
Absence of ER stress gene activation in islets from
NOD mice. Finally, we assessed whether ER stress was
present in islets of NOD mice. mRNA levels were com-
pared in islets isolated from non–diabetes-prone C57BL/6
mice and pre-diabetic and diabetic NOD mice. Blood
glucose levels were 5.3 	 0.4 mmol/l in pre-diabetic NOD
mice and 13.4 	 1.7 mmol/l in diabetic NOD mice. Using
real-time RT-PCR, we determined that the expression of
several ER stress genes were either downregulated or
unchanged in NOD islets compared with control C57BL/6
islets. Islet mRNA levels were reduced for BiP, GRP94, and
spliced XBP1 in pre-diabetic and diabetic NOD mice and
for ATF4 in diabetic NOD mice (Table 1). p58 mRNA levels
were reduced in islets of pre-diabetic NOD mice and were
further reduced in islets of diabetic NOD mice (P 
 0.05).
CHOP and Edem1 mRNA levels were unchanged in islets
of NOD mice both before and after the onset of diabetes
compared with their control C57BL/6 mice (Table 1). In
contrast, Fas and monocyte chemoattractant protein-1
mRNA levels were signiﬁcantly increased in islets of
pre-diabetic and diabetic NOD mice, indicative of the
autoimmune and inﬂammatory insult. Thus, in contrast to
db/db mice (19,31) and humans with type 2 diabetes
(19,20), there was no increase in ER stress gene expres-
sion in islets of NOD mice.
DISCUSSION
The mechanisms by which cytokines stimulate pancreatic
-cell death have been the subject of much attention
because of their potential relevance to type 1 diabetes
FIG. 8. siRNA-mediated silencing of CHOP expression in INS-1 cells
protects against palmitate- but not against cytokine-induced cell death.
INS-1 cells were transfected with CHOP ON-TARGETplus SMARTpool
siRNA or negative control nontargeting siRNA using DharmaFECT Trans-
fection Reagent and treated with 0.4 mmol/l palmitate coupled to 0.92%
BSA (A–D) or IL-1 (50 units/ml) and IFN- (100 units/ml) (E–H). A and
E: Western blot analysis of CHOP and cleaved caspase-3. -Actin served
as a loading control. CHOP (B and F) and cleaved caspase-3 bands (C and
G) were quantiﬁed by densitometry and are expressed as fold change
compared with untreated control siRNA. Results are means  SEM, n 
5–6 in each group. *P < 0.05, **P < 0.01 versus treated control siRNA. D
and H: Cell death was measured using a cell death detection ELISA.
Results are means  SEM, n  6–7 in each group. **P < 0.01 versus
palmitate-treated control siRNA.
TABLE 1
Changes to mRNA levels of genes involved in ER stress in islets
isolated from pre-diabetic and diabetic NOD mice
Pre-diabetic Diabetic
C57BL/6J NOD C57BL/6J NOD
ATF4 100 	 28 2 	 10 100 	 13 62 	 2*
BiP 100 	 38 4 	 5* 100 	 28 7 	 1**
GRP94 100 	 28 2 	 4** 100 	 97 2 	 4*
CHOP 100 	 4 115 	 17 100 	 13 124 	 8
Edem1 100 	 29 0 	 3 100 	 19 90 	 2
p58 100 	 47 8 	 5* 100 	 10 59 	 2**†
XBP1s 100 	 37 7 	 8* 100 	 46 9 	 2***
Fas 100 	 6 180 	 29* 100 	 4 931 	 93***††
MCP-1 100 	 6 372 	 50*** 100 	 18 5437 	 284***††
Data are means 	 SEM and are expressed as a percent of mRNA
levels in islets isolated from control C57BL/6J mice at the same time.
n  3–5 independent determinations per group. *P 
 0.05, **P 

0.01, ***P 
 0.001 for pre-diabetic and diabetic NOD mice versus
control C57BL/6J mice at the same time point. †P 
 0.05, ††P 
 0.001
for diabetic NOD mice versus pre-diabetic NOD mice.
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in cytokine-mediated cytotoxicity in -cells (6–8). Here,
we tested whether ER stress makes a necessary contribu-
tion to cytokine-induced -cell death and whether it
occurs in islets of the premier animal model of type 1
diabetes, the NOD mouse. Consistent with previous stud-
ies (6–8), we show that cytokines activate the UPR in
clonal -cells and cultured rodent islets. For the ﬁrst time,
we show that cytokines lead to increased phosphorylation
of PERK and thus activation of this ER stress sensor
pathway. This is accompanied by increased phosphoryla-
tion of EIF2 and transcriptional activation of ATF4 and
CHOP. Importantly, we show that this activation of the
UPR is not necessary for the associated -cell death.
Chemical and molecular approaches to increase the chap-
erone capacity of the ER failed to confer protection to the
toxic effects of cytokines, suggesting an ER stress–inde-
pendent mechanism of cell death. Furthermore, inhibition
of CHOP had no inﬂuence over cytokine-mediated -cell
death. The relevance of this to type 1 diabetes is demon-
strated by the fact that expressions of ER stress–respon-
sive proteins are either reduced or not changed, rather
than increased, in islets of NOD mice.
Importantly, our studies strengthen the case for ER
stress, providing a mechanism for lipotoxicity and the
reduced -cell mass that characterizes type 2 diabetes
(5,32). This is based on the observations that lipotoxicity
was signiﬁcantly reduced by CHOP knock down and by
the treatments of PBA and TMAO, chemical chaperones
that enhance ER functional capacity. This is consistent
with our previous studies indicating that BiP overexpres-
sion partially protects against the effects of lipid overex-
posure (19). With ER stress potentially also providing a
link between obesity and insulin resistance in liver and fat,
our studies, together with others (8,19,20,24,33,34), sug-
gest that ER stress may act as a common mechanism for
-cell failure and defective insulin signaling. The ﬁndings
highlight the potential for increasing chaperone capacity
of the ER as a therapeutic approach for type 2 diabetes
treatment by preventing -cell lipotoxicity and peripheral
insulin resistance.
There are several differences in cytokine and palmitate
signaling that may contribute to the divergent -cell re-
sponses to ER stress (5). Whereas cytokines induce nu-
clear factor-B activation, NO production, downregulation
of the sarcoendoplasmic reticulum pump Ca
2 ATPase 2b
(SERC2b), and ER Ca
2 depletion (7,8), palmitate induces
ER stress via nuclear factor-B–, NO–, and ER Ca
2–
independent mechanisms (8,34). Furthermore, unlike
palmitate (8,19), cytokines fail to activate ATF6 in -cells
(7), and, indeed, the presence of IFN- within the inﬂam-
matory milieu may actually lower the expression of ATF6/
XBP1-targeted genes (chaperones) and thus ER stress
defenses (35). We conﬁrmed this in our own studies,
ﬁnding slightly reduced BiP and p58 mRNA levels in 24-h
IL-1IFN-–treated INS-1 cells (data not shown). There
are also subtle differences in the way palmitate and
cytokines regulate CHOP transcription (36). Moreover,
prolonged phosphorylation of EIF2 leads to marked
potentiation of the deleterious effects of fatty acids but not
cytokines (37). Other studies have demonstrated that UPR
activation may in fact inhibit cytokine signaling (38).
Recently, cytokine-induced cell death and UPR activation
were dissociated on the basis that IL-1 failed to stimulate
caspase-3 activity (39).
Interestingly, BiP overexpression in NIT-1 insulinoma
cells was shown to lower cytokine-mediated cytotoxicity
(40), in opposition to our ﬁndings in INS-1 and MIN6 cells.
However, it is important to note that in the studies with
NIT-1 cells, BiP overexpression through unknown mecha-
nisms led to lowered cytokine-induced NO production and
increased superoxide dismutase activity (40). Thus, the
mechanism by which BiP overexpression protects NIT-1
cells may be secondary to effects of lowering NO and/or
increasing capacity of the cell to cope with reactive
oxygen species rather than to attenuation of ER stress. In
contrast, neither BiP overexpression (data not shown) nor
PBA treatment (Fig. 3) lowered cytokine-induced NO
production or iNOS expression in our studies.
In the present study, we provide evidence of differential
signaling mechanisms for the activation of JNK by palmi-
tate and cytokines. The ability of palmitate to increase
XBP1 splicing and of PBA to lower palmitate-induced
JNK1/2 phosphorylation is consistent with the possibility
that ER stress is necessary for palmitate-induced JNK
activation. On the other hand, the failure of cytokines to
activate XBP1 and of PBA to reverse cytokine-induced
JNK1/2 phosphorylation suggests that cytokine-mediated
activation of JNK occurs independently of ER stress.
Several previous studies have highlighted the importance
of JNK protein kinases in cytokine- (41,42) and palmitate-
induced (43) cell death and in T-cell–mediated killing of
-cells in NOD mice (44).
Our data suggesting a CHOP-independent mechanism of
cytokine-induced -cell death are at variance with prior
studies by Oyadomari et al. (6) that apportioned CHOP
with a modest contribution. This apparent discrepancy
might relate to important differences in experimental
design. Given that -cells appear especially sensitive to
disruption of ER stress signaling (16,17,45), it is possible
that developmental changes and alterations in cell differ-
entiation in CHOP (
/
) mice (15,46,47) may inﬂuence
outcomes from experiments using their islets ex vivo. In
contrast, our experiments were performed in otherwise
normal -cells without inﬂuence of potential changes in
cell development or differentiation, with similar results
found in pure -cell populations of INS-1 and MIN6 cells.
We conclude that although both cytokines and palmitate
induce ER stress in cultured -cells, UPR activation is
selectively necessary for lipotoxicity and not for cytokine-
induced -cell death. Furthermore, we did not ﬁnd evi-
dence of ER stress in islets of NOD mice, and it was not
found in islets of humans with type 1 diabetes either (20).
On the other hand, islets from type 2 diabetic patients may
be susceptible to ER stress induction after metabolic
challenge (48), thus underlining the potential importance
of ER stress and UPR activation in the development of
type 2 diabetes (19,20). These data support the view that
different mechanisms are responsible for -cell death in
type 1 and type 2 diabetes.
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